Transplantation Infection, Vaccination
Conditions
Brief summary
Vaccine preventable infections are a serious complication following pediatric solid organ transplant. Immunizations are a minimally invasive and cost-effective was to reduce these infections. Despite the importance of pre-transplant vaccination, the majority of pediatric solid organ transplant recipients are not up-to-date on age-appropriate immunizations at the time of transplant. The goal of this study is to pilot a novel health information technology immunization tool to improve immunization rates in pediatric solid organ transplant candidates.
Detailed description
Triads of parents, primary care physicians, and transplant sub-specialists will be enrolled to use a pre-transplant immunization tool while their child awaits transplant. The tool will provide information about vaccines, information about vaccine-preventable infections in the transplant population, a central easily accessible vaccine record, and a communication portal. The tool will also send vaccine reminders when vaccinations are due. The investigators will assess 1) the effectiveness of the tool in improving pre-transplant immunization rates, 2) the acceptability of the tool to users and 3) the feasibility of the tool.
Interventions
OTHERimmunization app
A transplant specific immunization app will be trialed that 1) provides vaccine information and education, 2) stores vaccine records and 3) provides reminders when vaccines are due
Sponsors
Agency for Healthcare Research and Quality (AHRQ)
University of Colorado, Denver
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
45 triads of parents, primary care physicians and subspecialists of children awaiting heart, liver and kidney transplantation will be enrolled to use a novel immunization tool (app).
Eligibility
Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Parent, primary care provider and sub-specialist of a child awaiting heart, liver or kidney transplant
Exclusion criteria
* Non English speaking * No access to a smart phone or computer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Effectiveness of Transplant Immunization Tool, as measured by number of patients with up-to-date vaccinations | Date of transplantation (up to 3 years post-enrollment) | We will assess whether the novel immunization tool improves pre-transplant vaccination rates. The number of participants who are up to date with vaccinations will be reported. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Acceptability and Feasibility of the Transplant Immunization Tool, as assessed by a questionnaire | Date of transplantation (up to 3 years post-enrollment) | We will assess whether the novel immunization tool is feasible and acceptable to users using a Likert scale with possible scores of 1-5, with 1 being least feasible/acceptable to the participant and 5 being the most feasible/acceptable. |
Countries
United States
Contacts
Primary ContactAmy Feldman, MD
Outcome results
None listed